Stock listing

NASDAQ:KZR Kezar Life Sciences, Inc. Stock

Home listing (NASDAQ) of Kezar Life Sciences, Inc.

Follow Kezar Life Sciences, Inc. into a list and get an email when it puts out news.

Kezar Life Sciences, Inc. logo
Ticker
NASDAQ:KZR
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Kezar Life Sciences, Inc. news

Kezar Life Sciences, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
2 in the last 12 months · 76 in all · newest Mar 12, 2026 · oldest 2019
Decks
8 decks · latest Nov 10, 2025

Where Kezar Life Sciences, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:KZR · Home listing · This pageNASDAQUnited StatesUSD
Lang & Schwarz:A40NJTLang & SchwarzGermanyEUR
LS Exchange:A40NJTLS ExchangeGermanyEUR
BOATS:KZRBOATSUnited StatesUSD
Tradegate:2KZ0TradegateGermanyEUR
Frankfurt:2KZ0FrankfurtGermanyEUR
gettex:2KZ0gettexGermanyEUR
Munich:2KZ0MunichGermanyEUR
Stuttgart:2KZ0StuttgartGermanyEUR

Decks

DeckKindSlidesDate
Technical Presentation (November 2025)Technical14 slidesNov 10, 2025
Technical Presentation (March 2025)Technical36 slidesMar 25, 2025
Technical Presentation (February 2025)Technical33 slidesFeb 27, 2025
Technical Presentation (2023)Technical11 slides2023
Investor Day (June 2022)Investor day27 slidesJun 27, 2022
Investor Day (November 2021)Investor day62 slidesNov 15, 2021
Technical Presentation (2020)Technical6 slides2020
Investor Presentation (October 2019)Investor deck21 slidesOct 3, 2019

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Franklin Berger
Other companies: Retension Pharmaceuticals, Inc. (Director · Since at least Oct 13, 2026); Atea Pharmaceuticals, Inc. (Director · Since at least Oct 29, 2020); ESSA Pharma Inc (Director · Since at least Oct 1, 2020); Rain Oncology Inc (Director · Apr 22, 2021 – Jan 26, 2024 · Past); Kineta Inc. (Director · Jun 27, 2019 – Jun 29, 2020 · Past); Atreca Inc (Director · Jun 19, 2019 – Jun 13, 2023 · Past); Five Prime Therapeutics Inc (Director · Jun 10, 2019 – Apr 16, 2021 · Past); Tocagen Inc (Director · May 29, 2019 – Oct 4, 2019 · Past); Immune Design Corp (Director · Apr 2, 2019 – Apr 2, 2019 · Past)
Director · Since at least Jun 25, 2019
Graham Cooper
Other companies: Beam Therapeutics Inc. (Director · Since at least Jun 4, 2025)
Director · Since at least Jun 18, 2025
Vassiliki Economides
Other companies: Gritstone bio, Inc. (EVP, CHIEF FINANCIAL OFFICER · Jun 23, 2021 – Apr 4, 2025 · Past)
SVP, Strategy & External Aff. · Mar 4, 2019 – Mar 29, 2021 · Past
Elizabeth GarnerDirector · Since at least Dec 18, 2019
Jason DingesDirector · Jun 20, 2018 – Jun 28, 2021 · Past
John Franklin FowlerDirector · Since at least Jun 20, 2018
Marc BelskyChief Financial Officer · Since at least May 11, 2026
Mark C SchillerChief Operating Officer · Since at least Mar 27, 2025
Nicholas Michael MordwinkinChief Business Officer · Jul 11, 2022 – Jan 7, 2024 · Past
Niti GoelChief Medical Officer · Jun 20, 2018 – Jan 6, 2019 · Past
All 12 people
PersonSeat
Pichi Luo ChiangSVP, Corporate Controller · Since at least Apr 1, 2025
Zung Phuong ToChief Development Officer · Since at least Apr 1, 2025

Open People

Log in to ask 6ix AI your own questions about Kezar Life Sciences, Inc.